TransMedics Group TMDX recently completed its strategic investment in Germany-based PAD Aviation service GmbH, marking a key ...

TransMedics Group, Inc. TMDX is well-poised for growth in the coming quarters, courtesy of its strength in Organ Care System ...

Innovations often (but not always) drive life-changing returns for the companies that engineer them and the people who get in on the ground floor. That's why investors should sometimes look toward ...

We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. TransMedics Group, Inc. (NASDAQ:TMDX) is ...

TransMedics Group (NASDAQ: TMDX) has emerged as a medical devices industry leader, capturing strong growth and climbing profitability from its organ transplant delivery system. Since the company's ...

To find out if TransMedics is a good growth stock to buy now, we'll need to weigh the reasons it soared against some of the challenges it faces. In a nutshell, TransMedics stock began 2025 in a ...

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...

Shares of organ transplant innovator TransMedics Group (NASDAQ: TMDX) fell 15.7% through Thursday trading, according to data from S&P Global Market Intelligence. TransMedics was the target of an ...

Specializing in organ preservation technology, this medical device innovator reported a notable insider sale amid ongoing ...

TransMedics is rated Buy as the market overreacts to Q1 margin pressure, while the core growth thesis remains intact. Read more on TMDX stock here.

TransMedics is helping improve organ transplantation thanks to its innovative organ storage system. The company has posted strong financial results over the past few years, and the stock is soaring.